WebDec 1, 2024 · Cosmetic results can be evaluated using various methods. The Harvard scale, which compares an overall cosmetic impression of the treated breast with the untreated … WebMar 21, 2024 · Prospective, Non-randomized, Single-arm.The objectives of this study are to evaluate cosmesis and perioperative complications associated with the use of intraoperative radiotherapy (IORT) at the time of partial mastectomy in patients with breast cancer and a prior history of radiation therapy.
The Allegheny General Modification of the Harvard Breast …
WebHarvard Breast Cosmesis Scale.17 The primary end point was the IBTR rate. The secondary end points were LRR, DM, and contralateral BC (CBC) rates, BC-specific survival (BCSS), and overall survival (OS), acute/late treatment-related toxicity, and cosmetic outcomes. Statistical Methods WebThe grade 1 seroma rate at 3 months was 20%, which dropped to 8% at 12 months; no events required intervention. At 12 months, 91% of patients reported an overall quality of life score as ≥8 of 10, and patient-reported cosmesis was good or excellent in 95%. All patients are alive without relapse at the last follow-up. dr. geoffrey mcleod do
3 fraction pencil-beam scanning proton accelerated partial breast ...
WebNov 21, 2024 · In addition, a modified Harvard Breast Cosmesis Scale was used to assess patient-reported cosmesis . Results. Between December 2015 and November 2024, 76 women underwent wide local excision with negative margins and received 3 fraction PBS proton APBI. The median time from surgery to the initiation of radiotherapy was 44 days … WebSep 10, 2014 · The BCCT.core software was used as a validated tool for objectively scoring cosmesis and computes a score based on symmetry, color, and scar visibility. All outcomes were assessed by the same investigator (AW). Results: A total of 33 patients had 1-year baseline and follow up photographs. WebJan 18, 2024 · The linear analog scale assessment (LASA), harvard breast cosmesis scale (HBCS), PRO-common terminology criteria for adverse events- PRO (PRO-CTCAE), and breast cancer treatment outcome scale (BCTOS) were used to assess quality of life (QoL), pain, fatigue, aesthetic and functional status, and breast cosmesis. ensheaths meaning